Depression has been studied for decades through a predominantly neurological and psychological lens — disrupted serotonin, negative thought patterns, adverse life events. These frameworks have been productive, but they have also been incomplete. A growing body of evidence now points to the immune system as a significant and underappreciated player in the biology of low mood, and the implications for how we understand and treat depression are considerable.

The Cytokine Hypothesis

Cytokines are small proteins secreted by immune cells that coordinate the inflammatory response. Their job is to signal danger, recruit immune cells to a site of infection or injury, and calibrate the intensity of the immune attack. They are essential and powerful. They are also, when chronically elevated, deeply disruptive to brain function. Researchers first noticed the connection between cytokines and mood through what is called sickness behavior. When humans or animals are acutely infected, they become withdrawn, lose appetite, stop engaging with social stimuli, experience fatigue, and develop low mood. This behavioral shift is not a psychological response to feeling unwell — it is an active program initiated by immune signals reaching the brain. Cytokines, including tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6, act on the brain to produce these behavioral changes. The purpose appears to be evolutionary: conserving energy for immune defense and reducing exposure to additional threats during a vulnerable period. The problem arises when this system stays activated outside of acute infection.

Chronic Inflammation and Its Sources

Modern life provides numerous routes to chronic low-grade inflammation. Poor diet, particularly diets high in processed foods and refined sugars, promotes inflammatory signaling. Obesity, particularly adipose tissue around the abdomen, is itself an active producer of inflammatory cytokines. Sleep deprivation elevates inflammatory markers within days. Chronic psychological stress activates the same immune pathways that physical threats do, because the body does not sharply distinguish between a predator and a hostile workplace. Early life adversity deserves particular mention. Research from the Avon Longitudinal Study of Parents and Children in the UK found that children who experienced significant adversity in their first years of life showed elevated C-reactive protein levels as young adults, long after the adverse conditions had passed. The immune system appears to encode early stress and remain in a state of heightened alert, a form of biological memory with long mental health consequences.

The Brain Under Inflammatory Pressure

When cytokines reach the brain, they alter several of the processes most relevant to mood. Serotonin synthesis is disrupted: the amino acid tryptophan, the raw material for serotonin, is diverted by inflammatory enzymes toward the production of kynurenine and its downstream metabolites, some of which are neurotoxic. Less tryptophan available for serotonin means less serotonin available to support mood. Neuroplasticity is also affected. Brain-derived neurotrophic factor (BDNF) — the protein most associated with the brain's ability to form new connections and adapt — is suppressed by elevated inflammatory cytokines. Lower BDNF is consistently found in depression, and it is one of the mechanisms through which inflammation is thought to maintain depressive states rather than merely triggering them. A team at the Max Planck Institute for Psychiatry published findings demonstrating that inflammatory markers predicted poorer response to standard antidepressant treatment, suggesting that patients with elevated inflammation represent a biologically distinct subgroup whose depression may require different approaches.

Who Is Most Vulnerable

Not everyone with high inflammation becomes depressed, and not everyone who is depressed has elevated inflammation. The inflammatory subtype of depression appears to affect roughly a third of people with major depressive disorder, based on current estimates, though the methodology for identifying it is still being standardized. People who are obese, who have autoimmune conditions, who have experienced significant early life stress, or who have not responded well to serotonergic antidepressants may be more likely to fall into this group. This is important because treating inflammatory depression with standard SSRIs alone may be inadequate. Anti-inflammatory interventions — ranging from dietary change and exercise to specific medications in research contexts — may need to be part of the picture.

What Can Be Done

Exercise is probably the most accessible and well-evidenced anti-inflammatory intervention for mood. Regular moderate exercise reduces circulating inflammatory markers, increases BDNF, and improves depression outcomes through mechanisms that are at least partly distinct from the psychological benefits of feeling physically capable. The anti-inflammatory effects of exercise are not small or theoretical; they are measurable in blood. Dietary patterns, particularly those rich in omega-3 fatty acids, polyphenols, and fiber, also shift the inflammatory balance in a direction associated with lower depression risk. Omega-3 supplementation specifically has accumulated reasonable evidence as an adjunctive treatment for depression, with effects thought to be partially mediated through reduced inflammation. Depression is not one disease. Recognizing that for some people it is fundamentally an immune-mediated condition opens treatment pathways that the conventional model has left closed.